Literature DB >> 6148520

Cryptogenic fibrosing alveolitis and Epstein-Barr virus: an association?

J M Vergnon, M Vincent, G de Thé, J F Mornex, P Weynants, J Brune.   

Abstract

13 patients with cryptogenic fibrosing alveolitis (CFA) and 12 with interstitial lung disease (ILD) of known cause were studied for their humoral response to herpes simplex virus (HSV), cytomegalovirus (CMV), and Epstein-Barr virus (EBV). Serum antibodies to HSV and CMV were within the normal range in all patients. 10 patients with CFA had raised serum antibodies to EBV, and IgA against viral-capsid antigen (VCA) was detectable in all 13. In the other 12 patients EBV serological profiles were normal and IgA against VCA was detectable in only 1 patient. The EBV antibody levels did not correlate with the level of circulating immune complexes, the presence of rheumatoid factors, or the cytological findings of the alveolitis. The presence of IgG against VCA in 5 CFA patients suggests local production of EBV-specific immunoglobulins. Elevated IgG and IgA against EBV in CFA may indicate non-specific depression of cell-mediated immunity or that EBV plays a part in the aetiology of CFA.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6148520     DOI: 10.1016/s0140-6736(84)90702-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  34 in total

Review 1.  In search of a cause of cryptogenic fibrosing alveolitis (CFA): one initiating factor or many?

Authors:  M Turner-Warwick
Journal:  Thorax       Date:  1998-08       Impact factor: 9.139

Review 2.  Review of cryptogenic fibrosing alveolitis, including current treatment guidelines.

Authors:  S C Bourke; H Clague
Journal:  Postgrad Med J       Date:  2000-10       Impact factor: 2.401

3.  Pulmonary fibrosis induced by γ-herpesvirus in aged mice is associated with increased fibroblast responsiveness to transforming growth factor-β.

Authors:  Payal N Naik; Jeffrey C Horowitz; Thomas A Moore; Carol A Wilke; Galen B Toews; Bethany B Moore
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-12-21       Impact factor: 6.053

4.  Right place, right time: the evolving role of herpesvirus infection as a "second hit" in idiopathic pulmonary fibrosis.

Authors:  Jonathan A Kropski; William E Lawson; Timothy S Blackwell
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-12-16       Impact factor: 5.464

5.  Modulation of lung inflammation by the Epstein-Barr virus protein Zta.

Authors:  James F Guenther; Jennifer E Cameron; Hong T Nguyen; Yu Wang; Deborah E Sullivan; Bin Shan; Joseph A Lasky; Erik K Flemington; Gilbert F Morris
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-09-03       Impact factor: 5.464

6.  In vivo levels and in vitro production of interferon-gamma in fibrosing interstitial lung diseases.

Authors:  C Prior; P L Haslam
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

Review 7.  Cellular mechanisms of tissue fibrosis. 7. New insights into the cellular mechanisms of pulmonary fibrosis.

Authors:  Christina E Barkauskas; Paul W Noble
Journal:  Am J Physiol Cell Physiol       Date:  2014-04-16       Impact factor: 4.249

8.  Conserved CDR 3 region of T cell receptor BV gene in lymphocytes from bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis.

Authors:  N Shimizudani; H Murata; H Keino; S Kojo; H Nakamura; Y Morishima; T Sakamoto; M Ohtsuka; K Sekisawa; M Sumida; T Sumida; T Matsuoka
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

Review 9.  Viruses in Idiopathic Pulmonary Fibrosis. Etiology and Exacerbation.

Authors:  Bethany B Moore; Thomas A Moore
Journal:  Ann Am Thorac Soc       Date:  2015-11

Review 10.  The epidemiology of interstitial lung disease and its association with lung cancer.

Authors:  G Raghu; F Nyberg; G Morgan
Journal:  Br J Cancer       Date:  2004-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.